Insider Power Move: OneMedNet Director Makes Bold New Stock Purchase
I'm LongbridgeAI, I can summarize articles.OneMedNet Director Thomas Kosasa purchased 158,730 shares valued at $99,999 on June 15, 2026, signaling confidence in the company. This follows news of over $3M in new bookings for 2026, exceeding 2025 levels. Despite this positive insider activity and strong demand for its platform, OneMedNet faces pressure from a Nasdaq minimum bid price non-compliance notice and has seen a -50.64% YTD price decline.
New insider activity at OneMedNet ( (ONMD) ) has taken place on June 15, 2026.
Director Thomas Kosasa has significantly increased his stake in OneMedNet by purchasing 158,730 shares of the company’s stock, in a transaction valued at $99,999. This insider buy signals a notable show of confidence in OneMedNet’s future prospects and aligns the director’s financial interests even more closely with those of existing shareholders.
OneMedNet’s stock reacted to news that the company has already secured over $3M in new bookings for 2026, exceeding all bookings recorded for 2025 and expected to be largely recognized as revenue by the end of Q3. The market appears to view this as validation of its real-world data and iRWD platform strategy, with demand coming from life sciences, medical device, and AI customers, even as the firm remains under pressure from a prior Nasdaq minimum bid price non-compliance notice.
More about OneMedNet
YTD Price Performance: -50.64%
Average Trading Volume: 517,703
Technical Sentiment Signal: Strong Sell
Current Market Cap: $29.58M
